TORNTPHARM.BOTORNTPHARM.BO
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +8.61% | +2.82% | +7.81% | +11.16% | +12.36% |
| Gross Profit Growth | +10.55% | +4.96% | +7.87% | +11.04% | +10.63% |
| EBITDA Growth | +14.45% | +9.92% | +7.95% | +11.29% | +11.13% |
| Operating Income Growth | +11.58% | +1.70% | +2.94% | -43.85% | -42.28% |
| Net Income Growth | +17.36% | +13.54% | +10.82% | +19.91% | +30.46% |
| EPS Growth | +17.18% | +13.67% | +10.85% | +19.93% | +30.52% |
| EPS Diluted Growth | +17.18% | +13.67% | +10.85% | +19.93% | +30.52% |
| Weighted Average Shares Growth | +0.11% | -0.12% | +0.03% | +0.01% | -0.04% |
| Weighted Average Shares Diluted Growth | +0.11% | -0.12% | +0.03% | +0.01% | -0.04% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +1.82% | +0.00% | +1.23% | +0.00% | +22.55% |
| Inventory Growth | +2.39% | +0.00% | +11.50% | +0.00% | +8.63% |
| Asset Growth | +2.33% | +0.00% | -0.47% | +0.00% | +2.83% |
| Book Value per Share Growth | +11.76% | +12.02% | +10.69% | +10.70% | +12.64% |
| Debt Growth | -30.36% | +0.00% | -20.39% | +0.00% | -9.72% |
| R&D Expense Growth | +9.85% | +18.90% | +7.91% | +16.30% | +7.59% |
| SG&A Expenses Growth | +7.95% | +10.69% | +21.25% | +10.00% | +17.13% |